Factor B Protein

Purified human Factor B protein


Product Specifications

Citations2
Description

Purified human Factor B protein

Storage

Store at -70°C or below. Avoid freeze/thaw.

Form

Frozen liquid. 10 mM Sodium phosphate, 145 mM NaCl, pH 7.2. No preservative, 0.22 µm filtered.

Concentration

1.0 mg/mL (refer to CoA for lot specific concentration)

Applications

See citations and technical data sheet for application info.

Ordering Information

For Research Use Only. Not for use in diagnostic procedures.
Catalog NumberA408
Catalog Number (CE)N/A
Size250 µL
Price (USD)$290.00
Price (EURO)255,00 €

Contact us

US Phone+1 (858) 552 1100
EU Phone+353 (91) 412 474
US Emailcontact-us@quidelortho.com
EU Emailcontact-emea@quidelortho.com

Specifications

Description

Purified human Factor B protein

Size250 µL
Storage

Store at -70°C or below. Avoid freeze/thaw.

Form

Frozen liquid. 10 mM Sodium phosphate, 145 mM NaCl, pH 7.2. No preservative, 0.22 µm filtered.

Concentration1.0 mg/mL (refer to CoA for lot specific concentration)
ApplicationsSee citations and technical data sheet for application info.
Purity>95% by SDS-PAGE
SourceNormal human serum
Activity>90% versus normal human serum standard.
Molecular Weight93,000 Da (single chain)
Background

Purified human complement Factor B. Factor B is one of the proteins unique to the Alternative Complement Pathway. The 93 kD Factor B protein is made up of a single peptide chain. When the alternative pathway is activated either directly or by the classical pathway via the amplification loop, C3b can bind whole Factor B. Factor D can then cleave Factor B in a single site to yield Ba and Bb. Bb can then become the enzymatically active constituent of the C3 and C5 alternative pathway convertases.

Citations

TitleYearApplicationsSample SpeciesSampleSample Details

Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo.

2017Dot BlotHuman

Serum

SPIO nanoworms

Extracellular vesicles from KSHV-infected endothelial cells activate the complement system

2017ELISAHuman

HUVEC Cells

KSHV infection